These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20383772)

  • 1. Dydrogesterone and other progestins in benign breast disease: an overview.
    Schindler AE
    Arch Gynecol Obstet; 2011 Feb; 283(2):369-71. PubMed ID: 20383772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of cyclic administration of progestagens on blood coagulation factors].
    Winkler UH; Lauck US; Ebert C; Schindler AE
    Zentralbl Gynakol; 1998; 120(1):32-7. PubMed ID: 9499549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dydrogesterone in hormone replacement therapy.
    Mueck AO; Seeger H; Bühling KJ
    Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

  • 6. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of benign pathological conditions of the breasts with progesterone and progestogens. The results according to the type of breast condition (260 case records) (author's transl)].
    Mauvais-Jarvis P; Sterkers N; Kuttenn F; Beauvais J
    J Gynecol Obstet Biol Reprod (Paris); 1978 Apr; 7(3):477-84. PubMed ID: 681701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dydrogesterone use in early pregnancy.
    Mirza FG; Patki A; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dydrogesterone--a unique progestogen.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S1. PubMed ID: 19781875
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
    Tskhay VB; Kovtun NM; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of dydrogesterone in the treatment of endometriosis and adenomyosis.
    Schweppe KW
    Maturitas; 2009 Dec; 65 Suppl 1():S23-7. PubMed ID: 19945806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dydrogesterone on the vascular system.
    Seeger H; Mueck AO
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologic bases of the treatment of diffuse benign breast diseases].
    Van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1976 Jun; 5(4):567-75. PubMed ID: 783246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchorionic hemorrhage treatment with dydrogesterone.
    Pelinescu-Onciul D
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():77-81. PubMed ID: 17943544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current therapeutic data concerning mastodynia and benign mastopathies].
    Mauvais-Jarvis P
    Therapeutique; 1972 Nov; 48(9):575-8. PubMed ID: 4650527
    [No Abstract]   [Full Text] [Related]  

  • 19. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I
    Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.